SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the crypto community debates its potential amidst broader market movements, particularly in relation to Bitcoin's performance. Discussions revolve around whether LTC can break free from BTC's influence and if it's poised for a significant rally, with some eyeing potential price targets.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

ICP is trending as the community discusses its recent price action and potential.  Conversations revolve around buying the dips, speculation about reaching higher price levels, and comparisons to other cryptocurrencies like ZEC.  The broader narrative highlights ICP's technology and its potential within the decentralized internet and AI space, with some anticipating significant growth.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending as the community discusses its recent acquisition of Lanteris Space Systems and potential implications for future contracts, including the Lunar Terrain Vehicle (LTV) project. Community members are weighing the impact of potential dilution against the benefits of expanding capabilities in the space sector. Optimism persists regarding $LUNR's long-term growth and strategic positioning within the evolving space economy.

The Singularity is a visionary project built around the story of ION, a humanoid AI robot who journeys through the quiet ruins of human civilization, guided by a glowing blue butterfly. The project blends narrative, art, and blockchain utility to explore the balance between artificial intelligence and the natural world, symbolizing harmony at the edge of technological singularity. The token serves as the foundation of this ecosystem, enabling community participation, creative expression, and future expansion into interactive experiences. Beyond its story-driven identity, the project aims to create a meaningful digital space where holders gain access to unique content, governance opportunities, and cross-platform collaborations that highlight the synergy of technology and nature. This is more than just a token; it is a gateway to an evolving narrative-driven universe with long-term growth potential.

The Singularity

Singularity Crypto is trending amid highly speculative social media chatter. The community is currently focused on potential price appreciation and using aggressive language.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as community members discuss its potential and recent price action. Some suggest user growth is driving the rally, while others await further upward movement. Bullish sentiment remains with many noting its AI capabilities and potential for long-term growth.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending amid speculation about upcoming strategic partnerships, particularly regarding sovereign AI programs and potential deals in the Middle East, which could be revealed in 2026. Community discussions focus on the potential for significant contract wins with Saudi Arabia and the UAE and the possibility of new big tech clients. Some investors suggest Microsoft is increasing its contract with Innodata, and bullish sentiment is bolstered by Innodata's position in the AI data sector, though bearish sentiment remains due to INOD's position relative to its moving averages.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is trending due to positive Phase 1 clinical data for its CTX310 in vivo gene-editing therapy, which showed significant lipid reductions and no serious safety issues. Community members are excited about the potential for this treatment to address heart disease and validate CRSP's in vivo LNP delivery platform, while some are discussing analyst price target adjustments and upcoming catalysts.

Klarna Group Plc operates as an investment holding company. It provides an e-commerce payment solutions for merchants and shoppers. The firm connect an array of different financial services and commerce organizations, from PSPs, traditional banks, card networks and open banking providers, to commerce enablers, technology partners, in-store payments providers and shipping and return logistics providers. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna ($KLAR) is trending as investors discuss its recent IPO performance and future catalysts. Community chatter revolves around its AI integration and potential to disrupt traditional banking, while some express concerns about short selling and market manipulation. The stock is also being compared to competitors like Affirm ($AFRM) within the Buy Now, Pay Later sector, with discussions on market share and growth strategies.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene Corp. is trending amid discussions around potential ACA subsidy extensions and government shutdown negotiations, with community members weighing the potential impacts on the healthcare sector. Trump's stance on sending federal health insurance money directly to individuals is also fueling debate, with some viewing it as potentially beneficial for insurers like CNC. Traders are actively discussing potential entry and exit points, as well as the stock's technical strength in a volatile market.

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita ($DVA) is trending amidst discussions around kidney care, reimbursement clarity, and real-world evidence, particularly concerning TDAPA extension requests. The community is focused on DaVita's operational excellence, contrasting their approach to infection prevention (CBRSIs) with competitors like Fresenius and the potential impact of products like DefenCath on patient mortality rates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bank of New York Mellon Corp Has $120.51 Million Stock Position in Insmed, Inc. $INSM

Bank of New York Mellon Corp lowered its holdings in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) by 4.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund...

C WorldWide Group Holding A S Cuts Stock Position in Insmed, Inc. $INSM

C WorldWide Group Holding A S lessened its position in Insmed, Inc. (NASDAQ:INSM - Free Report) by 15.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange...

Insider Selling: Insmed (NASDAQ:INSM) Insider Sells 27,130 Shares of Stock

Insmed, Inc. (NASDAQ:INSM - Get Free Report) insider Michael Alexander Smith sold 27,130 shares of the firm's stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an...

Guru Fundamental Report for INSM

Below is Validea's guru fundamental report for INSMED INC (INSM). Of the 22 guru strategies we follow, INSM rates highest using our Quantitative Momentum Investor model based on the published...

Insmed To Present at November and December 2025 Investor Conferences

Insmed To Present at November and December 2025 Investor Conferences Insmed To Present at November and December 2025 Investor Conferences PR Newswire BRIDGEWATER, N.J., Nov. 5, 2025 BRIDGEWATER...

Latest read on rare disease gene therapy from Insmed CEO Will Lewis

Will Lewis, Insmed CEO, joins 'Fast Money' to talk Insmed's rare gene therapy development, demand, and quarterly results...

Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake

INSM shares jump 16% as Brinsupri's strong debut offset wider Q3 losses, lifting revenue 52% year over year.

Insmed (INSM) Reports Q3 Loss, Beats Revenue Estimates

Insmed (INSM) delivered earnings and revenue surprises of -32.58% and +24.16%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update

Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update PR Newswire BRIDGEWATER, N.J., Oct...

Gear Up for Insmed (INSM) Q3 Earnings: Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Insmed (INSM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insmed Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$1.26	--	--	N/A
Q3 '25	-$1.33	-$1.75	-31.71%	MISSED
Q2 '25	-$1.29	-$1.70	-31.51%	MISSED
Q1 '25	-$1.34	-$1.42	-6.07%	MISSED
Q4 '24	-$1.16	-$1.32	-13.38%	MISSED

INSM
Insmed Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest INSM News

INSMInsmed Inc